Skip to main content
NVDA-0.16%GOOGL+0.06%AAPL-0.05%MSFT0.00%AMZN+0.07%TSM-0.05%AVGO-0.16%TSLA-0.34%META-0.33%BRK-B-0.02%LLY-0.27%WMT+0.11%MU-0.47%JPM0.00%AMD-0.66%XOM+0.02%V+0.03%ASMLa+0.15%INTC-0.88%JNJ0.00%ORCL-0.01%0700.HK-0.07%CSCO-0.02%COST+0.01%MA+0.03%1398.HK-0.22%CAT+0.02%LRCX-0.01%CVX+0.06%ABBV+0.04%NFLX-0.11%BAC-0.01%UNH+0.37%KO+0.01%AP2d+0.09%AMAT0.00%0857.HK0.00%PG+0.05%1816.HK-29.98%ARM-0.02%0005.HK+0.17%HSBA.L+0.06%MS+0.02%GE+0.05%9988.HK+0.11%HD-0.02%BABA-0.16%PM+0.01%GS-0.07%AZN+0.06%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%AUDNZD0.00%AUDSGD0.00%AUDUSD0.00%CADCHF0.00%CADJPY0.00%CHFJPY0.00%CHFNOK0.00%CHFSEK0.00%CHFSGD0.00%EURAUD0.00%EURCAD0.00%EURCHF0.00%EURCNH0.00%EURCZK0.00%EURDKK0.00%EURGBP0.00%EURHKD0.00%EURJPY0.00%EURNOK0.00%EURNZD0.00%EURPLN0.00%EURSEK0.00%EURSGD0.00%EURUSD0.00%EURZAR0.00%GBPAUD0.00%GBPCAD0.00%GBPCHF0.00%GBPJPY0.00%GBPNZD0.00%GBPSGD0.00%GBPUSD0.00%GBPZAR0.00%NOKJPY0.00%NZDCAD0.00%NZDCHF0.00%NZDJPY0.00%NZDMXN0.00%NZDSGD0.00%NZDUSD0.00%PLNJPY0.00%SGDJPY0.00%USDCAD0.00%USDCHF0.00%USDCNH0.00%USDDKK0.00%USDHKD0.00%USDJPY0.00%USDMXN0.00%USDNOK0.00%USDPLN0.00%USDSEK0.00%USDSGD0.00%USDTHB0.00%USDTRY0.00%AUDCAD0.00%USDZAR0.00%AUDCHF0.00%AUDDKK0.00%AUDJPY0.00%AUDNOK0.00%C10.00%GAGUSD0.00%GAUUSD0.00%HG10.00%S10.00%UKOIL0.00%USOIL0.00%W10.00%XAGUSD0.00%XAUUSD0.00%XNGUSD0.00%XPTUSD0.00%BTCUSDT-0.18%BTCUSD+0.03%ETHUSD-0.13%USDTUSD+0.06%BNBUSDT+3.68%XRPUSD+0.06%SOLUSD-0.08%TRXUSDT+0.15%DOGEUSD-0.22%ZECUSDT-0.98%ADAUSDT-1.35%BCHUSDT+0.03%XMRUSDT+0.12%LINKUSD-0.02%XLMUSDT-16.66%XLMUSD+0.12%TONUSD-0.11%LTCUSD-0.01%AVAXUSDT-1.26%SUIUSD+0.07%HBARUSDT+0.14%SUIUSDT+11.78%TONUSDT+40.11%TAOUSDT-0.33%UNIUSD+0.04%DOTUSDT+0.20%UNIUSDT+8.08%NEARUSDT+53.33%PEPEUSD+10342754.03%ICPUSDT-0.81%AAVEUSD-0.10%ETCUSDT+5.53%ONDOUSDT+0.08%ATOMUSDT-0.02%WLDUSDT+0.06%JUPUSDT-0.63%ARBUSDT-0.03%PENGUUSDT+99687.77%INJUSDT-0.42%FETUSDT-0.37%STXUSDT-0.42%SEIUSDT-0.24%TIAUSDT-0.14%IMXUSDT-0.14%GRTUSDT-0.30%OPUSDT-0.26%IOTAUSDT+0.12%PYTHUSDT-0.01%AXSUSDT-0.13%WIFUSDT+0.08%NVDA-0.16%GOOGL+0.06%AAPL-0.05%MSFT0.00%AMZN+0.07%TSM-0.05%AVGO-0.16%TSLA-0.34%META-0.33%BRK-B-0.02%LLY-0.27%WMT+0.11%MU-0.47%JPM0.00%AMD-0.66%XOM+0.02%V+0.03%ASMLa+0.15%INTC-0.88%JNJ0.00%ORCL-0.01%0700.HK-0.07%CSCO-0.02%COST+0.01%MA+0.03%1398.HK-0.22%CAT+0.02%LRCX-0.01%CVX+0.06%ABBV+0.04%NFLX-0.11%BAC-0.01%UNH+0.37%KO+0.01%AP2d+0.09%AMAT0.00%0857.HK0.00%PG+0.05%1816.HK-29.98%ARM-0.02%0005.HK+0.17%HSBA.L+0.06%MS+0.02%GE+0.05%9988.HK+0.11%HD-0.02%BABA-0.16%PM+0.01%GS-0.07%AZN+0.06%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%AUDNZD0.00%AUDSGD0.00%AUDUSD0.00%CADCHF0.00%CADJPY0.00%CHFJPY0.00%CHFNOK0.00%CHFSEK0.00%CHFSGD0.00%EURAUD0.00%EURCAD0.00%EURCHF0.00%EURCNH0.00%EURCZK0.00%EURDKK0.00%EURGBP0.00%EURHKD0.00%EURJPY0.00%EURNOK0.00%EURNZD0.00%EURPLN0.00%EURSEK0.00%EURSGD0.00%EURUSD0.00%EURZAR0.00%GBPAUD0.00%GBPCAD0.00%GBPCHF0.00%GBPJPY0.00%GBPNZD0.00%GBPSGD0.00%GBPUSD0.00%GBPZAR0.00%NOKJPY0.00%NZDCAD0.00%NZDCHF0.00%NZDJPY0.00%NZDMXN0.00%NZDSGD0.00%NZDUSD0.00%PLNJPY0.00%SGDJPY0.00%USDCAD0.00%USDCHF0.00%USDCNH0.00%USDDKK0.00%USDHKD0.00%USDJPY0.00%USDMXN0.00%USDNOK0.00%USDPLN0.00%USDSEK0.00%USDSGD0.00%USDTHB0.00%USDTRY0.00%AUDCAD0.00%USDZAR0.00%AUDCHF0.00%AUDDKK0.00%AUDJPY0.00%AUDNOK0.00%C10.00%GAGUSD0.00%GAUUSD0.00%HG10.00%S10.00%UKOIL0.00%USOIL0.00%W10.00%XAGUSD0.00%XAUUSD0.00%XNGUSD0.00%XPTUSD0.00%BTCUSDT-0.18%BTCUSD+0.03%ETHUSD-0.13%USDTUSD+0.06%BNBUSDT+3.68%XRPUSD+0.06%SOLUSD-0.08%TRXUSDT+0.15%DOGEUSD-0.22%ZECUSDT-0.98%ADAUSDT-1.35%BCHUSDT+0.03%XMRUSDT+0.12%LINKUSD-0.02%XLMUSDT-16.66%XLMUSD+0.12%TONUSD-0.11%LTCUSD-0.01%AVAXUSDT-1.26%SUIUSD+0.07%HBARUSDT+0.14%SUIUSDT+11.78%TONUSDT+40.11%TAOUSDT-0.33%UNIUSD+0.04%DOTUSDT+0.20%UNIUSDT+8.08%NEARUSDT+53.33%PEPEUSD+10342754.03%ICPUSDT-0.81%AAVEUSD-0.10%ETCUSDT+5.53%ONDOUSDT+0.08%ATOMUSDT-0.02%WLDUSDT+0.06%JUPUSDT-0.63%ARBUSDT-0.03%PENGUUSDT+99687.77%INJUSDT-0.42%FETUSDT-0.37%STXUSDT-0.42%SEIUSDT-0.24%TIAUSDT-0.14%IMXUSDT-0.14%GRTUSDT-0.30%OPUSDT-0.26%IOTAUSDT+0.12%PYTHUSDT-0.01%AXSUSDT-0.13%WIFUSDT+0.08%
BAYNd
Biotech and pharma stock chart showing volatility as investors reassess sector valuations

Biotech, Pharma Stocks Draw Fresh Valuation Focus

Drug and biotech names spark volatility as rallies and discounts fuel fresh investor valuation debates.

April 2, 2026

4 min read